Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: Economic analysis of a phase 4 randomized, controlled trial

Teresa L. Kauf, Robert S. Svatek, Gilad Amiel, Timothy L. Beard, Sam S. Chang, Amr Fergany, R. Jeffrey Karnes, Michael Koch, Jerome O'Hara, Cheryl T. Lee, Wade J. Sexton, Joel W. Slaton, Gary D. Steinberg, Shandra S. Wilson, Lee Techner, Carolyn Martin, Jessica Moreno, Ashish M. Kamat

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint Dive into the research topics of 'Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: Economic analysis of a phase 4 randomized, controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences